Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 108,779 | 102,231 | 100,317 | 99,212 | 97,791 |
| Cost of Goods | 85,562 | 79,477 | 79,932 | 74,877 | 75,480 |
| Gross Profit | 23,217 | 22,754 | 20,385 | 24,335 | 22,311 |
| Operating Expenses | 10,413 | 14,525 | 11,859 | 13,234 | 10,561 |
| Operating Income | 13,366 | 8,706 | 9,458 | 11,978 | 12,230 |
| Interest Expense | 2,017 | 2,003 | 2,037 | 2,191 | 2,075 |
| Pre-tax Income | 11,349 | 6,703 | 7,421 | 9,787 | 10,155 |
| Income Tax | 3,115 | 1,877 | 2,000 | 2,622 | 2,615 |
| Net Income Continuous | 8,234 | 4,826 | 5,421 | 7,165 | 7,540 |
| Net Income Discontinuous | -929 | -2,354 | -11,958 | -152 | -1,645 |
| Net Income | $7,305 | $2,472 | $-6,537 | $7,013 | $5,895 |
| EPS Basic Total Ops | 0.14 | 0.05 | -0.12 | 0.12 | 0.10 |
| EPS Basic Continuous Ops | 0.16 | 0.09 | 0.10 | 0.12 | 0.13 |
| EPS Basic Discontinuous Ops | -0.02 | -0.05 | -0.22 | 0.00 | -0.03 |
| EPS Diluted Total Ops | 0.13 | 0.05 | -0.11 | 0.11 | 0.10 |
| EPS Diluted Continuous Ops | 0.15 | 0.09 | 0.10 | 0.11 | 0.13 |
| EPS Diluted Discontinuous Ops | -0.02 | -0.04 | -0.21 | 0.00 | -0.03 |
| EBITDA(a) | $17,358 | $13,048 | $14,048 | $18,397 | $17,028 |